The general life expectancy of patients with hepatocellular carcinoma cannot be generalized, and the specific survival time is related to the clinical stage of the disease, the treatment effect, the actual situation of the patients themselves and other factors.
Generally speaking, the earlier the hepatocellular carcinoma is detected, diagnosed and treated, the longer the life expectancy of patients, and early treatment is recommended.
Clinically, “5-year survival rate” is generally used to roughly assess the survival rate of patients with hepatocellular carcinoma. It is worth mentioning that the 5-year survival rate of early-stage hepatocellular carcinoma can reach 70% after systematic treatment. If hepatocellular carcinoma patients are treated with comprehensive treatment such as surgical resection, the overall 5-year survival rate may be roughly around 20%;
As for advanced hepatocellular carcinoma patients, the 5-year survival rate is less than 5%.
It should be noted that patients with hepatocellular carcinoma should go to the hospital in time and actively cooperate with doctors for treatment, which can improve the survival rate.